IRIS Accounts Production v25.4.0.155 14792966 Board of Directors 1.5.24 30.4.25 30.4.25 false true false false false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 14792966 2024-04-30 14792966 2025-04-30 14792966 2024-05-01 2025-04-30 14792966 2023-04-10 14792966 2023-04-11 2024-04-30 14792966 2024-04-30 14792966 ns15:EnglandWales 2024-05-01 2025-04-30 14792966 ns14:PoundSterling 2024-05-01 2025-04-30 14792966 ns10:Director1 2024-05-01 2025-04-30 14792966 ns10:PrivateLimitedCompanyLtd 2024-05-01 2025-04-30 14792966 ns10:Micro-entities 2024-05-01 2025-04-30 14792966 ns10:AuditExemptWithAccountantsReport 2024-05-01 2025-04-30 14792966 ns10:SmallCompaniesRegimeForAccounts 2024-05-01 2025-04-30 14792966 ns10:FullAccounts 2024-05-01 2025-04-30 14792966 ns10:Director2 2024-05-01 2025-04-30 14792966 ns10:CompanySecretary1 2024-05-01 2025-04-30 14792966 ns10:RegisteredOffice 2024-05-01 2025-04-30 14792966 ns5:CurrentFinancialInstruments 2025-04-30 14792966 ns5:CurrentFinancialInstruments 2024-04-30

REGISTERED NUMBER: 14792966 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

30 APRIL 2025

FOR

YMG MEDICAL LIMITED

YMG MEDICAL LIMITED (BY SHARES) (REGISTERED NUMBER: 14792966) |

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 APRIL 2025

Page |

| Company Information | 1 |

| Chartered Certified Accountants' Report | 2 |

| Statement of Financial Position | 3 |

| YMG MEDICAL LIMITED (BY SHARES) |

COMPANY INFORMATION

FOR THE YEAR ENDED 30 APRIL 2025

| DIRECTORS: | Dr Y M Gerhard

| Dr A U Gerhard

| SECRETARY: | Dr A U Gerhard

| REGISTERED OFFICE: | Chips Cottage

| Stocking Green

| Radwinter

| Saffron Walden

| Essex

| CB10 2SS

| REGISTERED NUMBER: | 14792966 (England and Wales)

| ACCOUNTANTS: | Bentens

| Chartered Certified Accountants

| Abbey House

| 51 High Street

| Saffron Walden

| Essex

| CB10 1AF

CHARTERED CERTIFIED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS

ON THE UNAUDITED FINANCIAL STATEMENTS OF

YMG MEDICAL LIMITED (BY SHARES)

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Statement of Financial Position. Readers are cautioned that the Income Statement is not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of YMG Medical Limited for the year ended 30 April 2025 which comprise the Income Statement, Statement of Financial Position and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at accaglobal.com/rulebook.

This report is made solely to the Board of Directors of YMG Medical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of YMG Medical Limited and state those matters that we have agreed to state to the Board of Directors of YMG Medical Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at

https://www.accaglobal.com/gb/en/technical-activities/technical-resources-

search/2009/october/factsheet-163-audit-exempt-companies.html.

To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that YMG Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of YMG Medical Limited. You consider that YMG Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of YMG Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Bentens

Chartered Certified Accountants

Abbey House

51 High Street

Saffron Walden

Essex

CB10 1AF

20 January 2026

YMG MEDICAL LIMITED (BY SHARES) (REGISTERED NUMBER: 14792966) |

STATEMENT OF FINANCIAL POSITION

30 APRIL 2025

| 2025 | 2024 |

£ | £ | £ | £ |

FIXED ASSETS | 70,000 |  | 70,000 |  |

CURRENT ASSETS | 26,345 |  | 2,045 |  |

CREDITORS

Amounts falling due within one year | (97,659 | ) | (72,500 | ) |

NET CURRENT LIABILITIES | (71,314 | ) | (70,455 | ) |

TOTAL ASSETS LESS CURRENT LIABILITIES | (1,314 | ) | (455 | ) |

CAPITAL AND RESERVES | (1,314 | ) | (455 | ) |

NOTE TO THE FINANCIAL STATEMENTS

1. | AVERAGE NUMBER OF EMPLOYEES

| The average number of employees during the year was 2 (2024 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 20 January 2026 and were signed on its behalf by:

Dr A U Gerhard - Director